Patents Assigned to NOVA PROTEINS S.A. DE C.V.
  • VNAR HAVING ANTI-ANGIOGENIC ACTIVITY IN SOLID TUMOURS OF PET ANIMALS
    Publication number: 20200165331
    Abstract: The present invention relates to a novel vNAR protein of SEQ ID No: 1 capable of inhibiting the activity of VEGF in carnivorous mammals of the Canis and Felis genera, thereby inhibiting solid tumors growth of both genres.
    Type: Application
    Filed: April 20, 2018
    Publication date: May 28, 2020
    Applicants: CENTRO DE INVESTIGACIÓN CIENTÍFICA Y DE EDUCACIÓN SUPERIOR DE ENSENADA, BAJA CALIFORNIA, LABORATORIOS SILANES, S.A. DE C.V., TERACLÓN IDF, NOVA PROTEINS S.A. DE C.V.
    Inventors: Alexei Fedorovish LICEA NAVARRO, Dalia Vanessa MILLÁN GÓMEZ, Liliana Noemi SÁNCHEZ CAMPOS, Carolina ELOSUA PORTUGAL, Jorge Fernando PANIAGUA SOLÍS, Salvador DUEÑAS ESPINOZA